(Q64129081)

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Vaccinated children get milder measles infection: a community study from Guinea-Bissau

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Rubella, measles and mumps antibodies following vaccination of children. A potential rubella problem

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Measles mortality. Analysis of the primary cause of death

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Booster vaccination with further live attenuated measles vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

A clinical and serologic study of 103 children with measles vaccine failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Urban measles in the vaccine era: A clinical, epidemiologic, and serologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

The Functions and Inhibition of the Membrane Glycoproteins of Paramyxoviruses and Myxoviruses and the Role of the Measles Virus M Protein in Subacute Sclerosing Panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Loss of maternal measles antibody during infancy in an African city

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

The epidemiology of measles in a partially vaccinated population in an African city: implications for immunization programs

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

A persistent outbreak of measles despite appropriate prevention and control measures

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

SURVIVAL OF MEASLES VIRUS IN AIR.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Propagation in tissue cultures of cytopathogenic agents from patients with measles

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Isolation of measles virus at autopsy in cases of giant-cell pneumonia without rash

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Measles pneumonia in young adults. An analysis of 106 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Epidemic Measles and Rubella in Air Force Recruits: Impact of Immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Measles Encephalomyelitis — Clinical and Immunologic Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Measles outbreak in a fully immunized secondary-school population

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Measles and rubella in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Development and Evaluation of the Moraten Measles Virus Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

The Opportunity and Obligation to Eliminate Measles From the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Measles vaccines used in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

The case for global measles eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Measles mortality and vaccine efficacy in rural West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Measles and measles immunity in children infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Present status of measles and rubella immunization in the United States: A medical progress report

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

STUDIES ON IMMUNITY TO MEASLES

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Further-attenuated measles vaccine: characteristics and use.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Maternally derived measles immunity in era of vaccine-protected mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

A seroepidemiologic study of a measles epidemic in a highly immunized population

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Patterns of transmission in measles outbreaks in the United States, 1985-1986.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

The role of secondary vaccine failures in measles outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Live measles vaccine: a 21 year follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Risk factors for fatal measles infections

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Severe measles: some unanswered questions

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

The plaque-neutralization test as a measure of prior exposure to measles virus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Epidemiology and specific prophylaxis of measles.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Measles vaccine failure after documented seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Measles: clinical features. Pathogenesis, pathology and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Epidemic Measles in a Highly Vaccinated Population

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Reported measles in persons immunologically primed by prior vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Measles control efforts in urban Africa complicated by high incidence of measles in the first year of life

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Additional evidence against measles vaccine administration to infants less than 12 months of age: Altered immune response following active/passive immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Need for measles revaccination in adolescents: correlation with birth date prior to 1972

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Enzyme-linked immunosorbent assay for detection of measles antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021

Persistent measles infection of the central nervous system: subacute sclerosing panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936907-3

7 January 2021